Glucosamine Complex – joint care backed by science

Current clinical research shows that the right combination of glucosamine, chondroitin and MSM can support joint structures, support cartilage and contribute to freer movement in the early stages of discomfort. It is on this scientific basis that we have created Glucosamine Complex, an expertly balanced combination for maximum effectiveness.

The product supports the natural recovery processes in joint tissues, supports flexibility and long-term comfort in movement. The selected active ingredients are in optimal doses, in accordance with clinically studied amounts, and the goal is one – a real result. Because an active life should not be a compromise, but an informed choice.

Let’s also answer the fundamental question here:

Can dietary supplements, and in particular Glucosamine Complex, slow down diseases related to the musculoskeletal system?

Take for example medical data related to osteoarthritis:

Osteoarthritis has long been accepted as an inevitable part of aging, but modern medicine is increasingly looking for ways to slow its development in the early stages. This is why interest in glucosamine, chondroitin sulfate and methylsulfonylmethane is growing. They are seen as a possible link between supplements and long-term joint protection, although the scientific debate about their actual effectiveness continues.

A randomized clinical trial of 147 patients with grade 1 and 2 knee osteoarthritis according to the Kellgren-Lawrence classification compared 3 groups of patients. The first cohort took a combination of glucosamine and chondroitin, the second took a combination of glucosamine, chondroitin, and methylsulfonylmethane, and the third group was placebo. After 12 weeks, the most significant improvement in knee joint pain and functionality was seen with the triple combination. Glucosamine and chondroitin alone showed no significant effect, suggesting a possible key role for MSM in mild forms of osteoarthritis.

A systematic review of 146 clinical trials showed that over 90 percent of them reported positive results for the effectiveness of glucosamine and chondroitin for osteoarthritis and joint pain. The most commonly used doses are 1500 mg glucosamine and 1200 mg chondroitin daily.

Anti-inflammatory effects, slowing of degenerative processes in joint structures and reduction of markers associated with their degradation (e.g. MMP-3) are observed.

The European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) puts glucosamine sulfate and chondroitin sulfate on the first line of intake for long-term symptom control.

Long-term studies have also shown the potential for slower disease progression, lower risk of joint replacement and reduced need for other medications. In addition to the clinical benefits, the therapy is also associated with a significant reduction in healthcare costs.

In summary, the totality of the clinical, pharmacological and economic data suggests that glucosamine sulfate, chondroitin sulfate and, in some cases, methylsulfonylmethane contained in Glucosamine Complex may have an important role in the early and long-term treatment of osteoarthritis and joint disease.

Sources used:

1. BADEN, Kyrie Eleyson R.; HOEKSEMA, Sarah L.; GIBSON, Nathan; GADI, Divine N.; CRAIG, Eliya; DRAIME, Juanita A.; TUBB, Stephanie M.; CHEN, Aleda M. H. The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review. Nutrients, 2025, 17(13), 2093. Available at: The Safety and Efficacy of Glucosamine and/or Chondroitin in Humans: A Systematic Review – PMC

2. BRUYÈRE, Olivier; ALTMAN, Roy D.; REGINSTER, Jean-Yves. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism, 2016, 45(4 Suppl), pp. S12-S17. Available at: Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys – ScienceDirect

3. LUBIS, Andri M. T.; SIAGIAN, Carles; WONGGOKUSUMA, Erick; MARSETYO, Aldo F.; SETYOHADI, Bambang. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial. Acta Medica Indonesiana, 2017, 49(2), pp. 105-111. Available at: Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial – PubMed